UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOGO, KLIC, SYMC, HAIR, and FLKS
The Klein Law Firm
Jul. 06, 2018
NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm reminds investors that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Gogo Inc. (NASDAQ:GOGO) Lead Plaintiff Deadline: August 27, 2018 Class Period: February 27, 2017 - May 7, 2018
Allegations: Gogo’s 2Ku antenna had more reliability issues than the public was led to believe; Gogo’s 2Ku antennas required costly installation and faced costly remediation challenges or required replacement due to deicing fluids from planes infiltrating the 2Ku system, as well as manufacturing and software issues; consequently, Gogo would not be able to meet its previously issued 2018 guidance; and as a result, the company’s financial statements were materially false and misleading at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/gogo-inc?wire=3.
Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) Lead Plaintiff Deadline: July 10, 2018 Class Period: November 16, 2017 - May 10, 2018
Allegations: Kulicke and Soffa Industries, Inc.’s consolidated financial statements for the fiscal year ending September 30, 2017 could no longer be relied upon due to misstated warranty accruals; and as a result, Defendants' public statements were materially false and misleading at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/kulicke-and-soffa-industries-inc-2?wire=3.
Symantec Corp. (NASDAQ:SYMC)Lead Plaintiff Deadline: July 16, 2018Class Period: May 20, 2017 - May 10, 2018
Allegations: Symantec's internal controls over financial reporting were materially weak and deficient; Symantec's later disclosed "reporting of certain Non-GAAP measures including those that could impact executive compensation programs" would lead to heightened regulatory scrutiny by the SEC; and as a result, Symantec's public statements were materially false and misleading at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/symantec?wire=3.
Restoration Robotics, Inc. (NASDAQGM:HAIR) Lead Plaintiff Deadline: August 21, 2018 Class Period: purchased shares pursuant and/or traceable to the Company’s Initial Public Offering between October 12, 2017 and October 16, 2017
Allegations: The complaint alleges that Restoration Robotics negligently issued untrue statements of material facts in, and omitted to state material facts required to be stated from, the Offering Materials issued in connection with the Initial Public Offering. The complaint further alleges that as a result of the materially misleading Offering Materials, the Company’s stock price was artificially inflated at the time of the IPO.
Get additional information: http://www.kleinstocklaw.com/pslra-c/restoration-robotics-inc-hair?wire=3.
Flex Pharma, Inc. (NASDAQ:FLKS) Lead Plaintiff Deadline: August 20, 2018 Class Period: November 6, 2017 - June 12, 2018
Allegations: The Company overstated the viability and approval prospects for its product candidate FLX-787 for the treatment of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease; and as a result, Flex Pharma's public statements were materially false and misleading at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/flex-pharma-inc?wire=3.
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided. Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.